New York | 001-00035 | 14-0689340 | |||||||||||||||||||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | |||||||||||||||||||||
5 Necco Street | Boston, | MA | 02210 | ||||||||||||||||||||
(Address of principal executive offices) | (Zip Code) | ||||||||||||||||||||||
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common stock, par value $0.01 per share | GE | New York Stock Exchange | ||||||
1.250% Notes due 2023 | GE 23E | New York Stock Exchange | ||||||
0.875% Notes due 2025 | GE 25 | New York Stock Exchange | ||||||
1.875% Notes due 2027 | GE 27E | New York Stock Exchange | ||||||
1.500% Notes due 2029 | GE 29 | New York Stock Exchange | ||||||
7 1/2% Guaranteed Subordinated Notes due 2035 | GE /35 | New York Stock Exchange | ||||||
2.125% Notes due 2037 | GE 37 | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). | ||||||||
Emerging growth company | ☐ | |||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. | ☐ |
General Electric Company | |||||||||||
(Registrant) | |||||||||||
Date: February 27, 2023 | /s/ Thomas S. Timko | ||||||||||
Thomas S. Timko Vice President, Chief Accounting Officer and Controller |
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION | |||||||||||||||||||||||||||||
As of December 31, 2022 (in billions) | As Reported | GE HealthCare Separation (a) | GE HealthCare Debt Issuance (b) | Transaction Accounting Adjustments | Proforma | ||||||||||||||||||||||||
Cash, cash equivalents and restricted cash | $ | 17.3 | $ | (1.5) | $ | 2.0 | $ | (0.5) | (c) | $ | 17.3 | ||||||||||||||||||
Investment securities | 7.6 | — | — | 5.1 | (d) | 12.7 | |||||||||||||||||||||||
Current receivables | 18.0 | (3.4) | — | 0.2 | (e) | 14.8 | |||||||||||||||||||||||
Inventories, including deferred inventory costs | 17.4 | (2.5) | — | — | 14.9 | ||||||||||||||||||||||||
Current contract assets | 3.1 | (0.6) | — | — | 2.5 | ||||||||||||||||||||||||
All other current assets | 2.9 | (0.3) | — | 0.2 | (e) | 2.8 | |||||||||||||||||||||||
Current assets | 66.2 | (8.3) | 2.0 | 5.0 | 64.9 | ||||||||||||||||||||||||
Investment securities | 36.0 | — | — | — | 36.0 | ||||||||||||||||||||||||
Property, plant and equipment – net | 14.5 | (2.3) | — | — | 12.2 | ||||||||||||||||||||||||
Goodwill | 25.8 | (12.8) | — | — | 13.0 | ||||||||||||||||||||||||
Other intangible assets – net | 7.6 | (1.5) | — | — | 6.1 | ||||||||||||||||||||||||
Contract and other deferred assets | 6.0 | (0.2) | — | — | 5.8 | ||||||||||||||||||||||||
All other assets | 19.9 | (0.9) | — | (0.7) | (f) | 18.2 | |||||||||||||||||||||||
Deferred income taxes | 11.7 | (0.8) | — | (1.6) | (f)(g)(h) | 9.3 | |||||||||||||||||||||||
Total assets | $ | 187.8 | $ | (26.9) | $ | 2.0 | $ | 2.7 | $ | 165.6 | |||||||||||||||||||
Short-term borrowings | $ | 3.8 | $ | — | $ | — | $ | — | $ | 3.7 | |||||||||||||||||||
Accounts payable and equipment project payables | 18.6 | (3.3) | — | 0.1 | (e) | 15.4 | |||||||||||||||||||||||
Progress collections and deferred income | 18.1 | (1.9) | — | — | 16.2 | ||||||||||||||||||||||||
All other current liabilities | 16.4 | (2.0) | — | (0.1) | (e)(f)(h)(i)(j) | 14.4 | |||||||||||||||||||||||
Current liabilities | 56.9 | (7.2) | — | — | 49.7 | ||||||||||||||||||||||||
Deferred income | 2.0 | (0.6) | — | — | 1.4 | ||||||||||||||||||||||||
Long-term borrowings | 28.6 | (8.3) | 2.0 | (2.0) | (k) | 20.3 | |||||||||||||||||||||||
Insurance liabilities and annuity benefits | 33.3 | — | — | — | 33.3 | ||||||||||||||||||||||||
Non-current compensation and benefits | 16.0 | (0.5) | — | (5.1) | (f)(h) | 10.4 | |||||||||||||||||||||||
All other liabilities | 13.3 | (1.1) | — | — | 12.2 | ||||||||||||||||||||||||
Total liabilities | 150.2 | (17.7) | 2.0 | (7.1) | 127.4 | ||||||||||||||||||||||||
Preferred stock | — | — | — | — | — | ||||||||||||||||||||||||
Common stock | — | — | — | — | — | ||||||||||||||||||||||||
Accumulated other comprehensive income (loss) – net attributable to GE | (1.3) | 1.9 | — | (1.7) | (f)(h)(l) | (1.1) | |||||||||||||||||||||||
Other capital | 34.2 | 0.2 | — | — | 34.4 | ||||||||||||||||||||||||
Retained earnings | 84.7 | (11.3) | — | 11.5 | (m) | 84.9 | |||||||||||||||||||||||
Less common stock held in treasury | (81.2) | — | — | — | (81.2) | ||||||||||||||||||||||||
Total GE shareholders’ equity | 36.4 | (9.2) | — | 9.8 | 37.0 | ||||||||||||||||||||||||
Noncontrolling interests | 1.2 | — | — | — | 1.2 | ||||||||||||||||||||||||
Total equity | 37.6 | (9.2) | — | 9.8 | 38.2 | ||||||||||||||||||||||||
Total liabilities and equity | $ | 187.8 | $ | (26.9) | $ | 2.0 | $ | 2.7 | $ | 165.6 | |||||||||||||||||||
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF EARNINGS (LOSS) | |||||||||||||||||||||||
For the year ended December 31, 2022 (In billions; per-share amounts in dollars) | As Reported | GE HealthCare Separation (n) | Transaction Accounting Adjustments | Proforma | |||||||||||||||||||
Revenues | |||||||||||||||||||||||
Sales of equipment | $ | 32.0 | $ | (9.6) | $ | — | $ | 22.3 | |||||||||||||||
Sales of services | 41.6 | (8.8) | — | 32.8 | |||||||||||||||||||
Insurance revenues | 3.0 | — | — | 3.0 | |||||||||||||||||||
Total revenues | 76.6 | (18.5) | — | 58.1 | |||||||||||||||||||
Costs and expenses | |||||||||||||||||||||||
Cost of equipment sold | 30.4 | (6.7) | — | 23.7 | |||||||||||||||||||
Cost of services sold | 25.1 | (4.6) | — | 20.5 | |||||||||||||||||||
Selling, general and administrative expenses | 12.8 | (3.5) | (0.1) | (o) | 9.1 | ||||||||||||||||||
Separation costs | 1.0 | — | (0.3) | (p) | 0.7 | ||||||||||||||||||
Research and development | 2.8 | (1.0) | — | 1.8 | |||||||||||||||||||
Interest and other financial charges | 1.6 | (0.1) | (0.4) | (q) | 1.1 | ||||||||||||||||||
Debt extinguishment costs | 0.5 | — | — | 0.5 | |||||||||||||||||||
Insurance losses, annuity benefits and other costs | 2.7 | — | — | 2.7 | |||||||||||||||||||
Goodwill impairments | — | — | — | — | |||||||||||||||||||
Non-operating benefit costs (income) | (0.5) | — | 0.1 | (r) | (0.4) | ||||||||||||||||||
Total costs and expenses | 76.4 | (15.9) | (0.7) | 59.8 | |||||||||||||||||||
Other income | 1.2 | (0.1) | 3.8 | (s) | 4.9 | ||||||||||||||||||
Earnings (loss) from continuing operations before income taxes | 1.4 | (2.6) | 4.4 | 3.2 | |||||||||||||||||||
Benefit (provision) for income taxes | (0.5) | 0.6 | (0.1) | (v) | (0.1) | ||||||||||||||||||
Earnings (loss) from continuing operations | 0.9 | (2.1) | 4.3 | 3.2 | |||||||||||||||||||
Less net earnings (loss) attributable to noncontrolling interests | 0.1 | (0.1) | — | — | |||||||||||||||||||
Preferred stock dividends | (0.3) | — | — | (0.3) | |||||||||||||||||||
Net earnings (loss) from continuing operations attributable to GE common shareowners | $ | 0.6 | $ | (2.0) | $ | 4.3 | $ | 2.8 | |||||||||||||||
Per-share amounts | |||||||||||||||||||||||
Earnings (loss) from continuing operations | |||||||||||||||||||||||
Diluted earnings (loss) per share | $ | 0.53 | $ | 2.59 | |||||||||||||||||||
Basic earnings (loss) per share | $ | 0.53 | $ | 2.60 | |||||||||||||||||||
Average equivalent shares (in millions) | |||||||||||||||||||||||
Diluted | 1,101 | 1,101 | |||||||||||||||||||||
Basic | 1,096 | 1,096 |
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF EARNINGS (LOSS) | |||||||||||||||||||||||
For the year ended December 31, 2021 (In billions; per-share amounts in dollars) | As Reported | GE HealthCare Separation (n) | Transaction Accounting Adjustments | Proforma | |||||||||||||||||||
Revenues | |||||||||||||||||||||||
Sales of equipment | $ | 34.2 | $ | (9.1) | $ | — | $ | 25.1 | |||||||||||||||
Sales of services | 36.9 | (8.6) | — | 28.3 | |||||||||||||||||||
Insurance revenues | 3.1 | — | — | 3.1 | |||||||||||||||||||
Total revenues | 74.2 | (17.7) | — | 56.5 | |||||||||||||||||||
Costs and expenses | |||||||||||||||||||||||
Cost of equipment sold | 31.4 | (6.2) | — | 25.2 | |||||||||||||||||||
Cost of services sold | 22.5 | (4.3) | — | 18.2 | |||||||||||||||||||
Selling, general and administrative expenses | 11.7 | (3.5) | — | 8.2 | |||||||||||||||||||
Separation costs | — | — | — | — | |||||||||||||||||||
Research and development | 2.5 | (0.8) | — | 1.7 | |||||||||||||||||||
Interest and other financial charges | 1.9 | (0.1) | — | 1.8 | |||||||||||||||||||
Debt extinguishment costs | 6.5 | — | — | 6.5 | |||||||||||||||||||
Insurance losses, annuity benefits and other costs | 2.4 | — | — | 2.4 | |||||||||||||||||||
Goodwill impairments | — | — | — | — | |||||||||||||||||||
Non-operating benefit costs (income) | 1.8 | — | (0.6) | (r) | 1.1 | ||||||||||||||||||
Total costs and expenses | 80.7 | (15.0) | (0.6) | 65.1 | |||||||||||||||||||
Other income | 2.8 | (0.1) | — | 2.7 | |||||||||||||||||||
Earnings (loss) from continuing operations before income taxes | (3.7) | (2.9) | 0.7 | (5.9) | |||||||||||||||||||
Benefit (provision) for income taxes | 0.3 | 0.6 | (0.1) | (v) | 0.8 | ||||||||||||||||||
Earnings (loss) from continuing operations | (3.4) | (2.3) | 0.6 | (5.1) | |||||||||||||||||||
Less net earnings (loss) attributable to noncontrolling interests | (0.1) | — | — | (0.1) | |||||||||||||||||||
Preferred stock dividends | (0.2) | — | — | (0.2) | |||||||||||||||||||
Net earnings (loss) from continuing operations attributable to GE common shareowners | $ | (3.6) | $ | (2.3) | $ | 0.6 | $ | (5.2) | |||||||||||||||
Per-share amounts | |||||||||||||||||||||||
Earnings (loss) from continuing operations | |||||||||||||||||||||||
Diluted earnings (loss) per share | $ | (3.25) | $ | (4.78) | |||||||||||||||||||
Basic earnings (loss) per share | $ | (3.25) | $ | (4.78) | |||||||||||||||||||
Average equivalent shares (in millions) | |||||||||||||||||||||||
Diluted | 1,098 | 1,098 | |||||||||||||||||||||
Basic | 1,098 | 1,098 |
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF EARNINGS (LOSS) | |||||||||||||||||||||||
For the year ended December 31, 2020 (In billions; per-share amounts in dollars) | As Reported | GE HealthCare Separation (n) | Transaction Accounting Adjustments | Proforma | |||||||||||||||||||
Revenues | |||||||||||||||||||||||
Sales of equipment | $ | 37.6 | $ | (10.0) | $ | — | $ | 27.6 | |||||||||||||||
Sales of services | 35.4 | (8.0) | 0.2 | (u) | 27.6 | ||||||||||||||||||
Insurance revenues | 2.9 | — | — | 2.9 | |||||||||||||||||||
Total revenues | 75.8 | (18.0) | 0.2 | 58.0 | |||||||||||||||||||
Costs and expenses | |||||||||||||||||||||||
Cost of equipment sold | 35.2 | (6.6) | — | 28.7 | |||||||||||||||||||
Cost of services sold | 22.6 | (4.1) | 0.2 | (u) | 18.7 | ||||||||||||||||||
Selling, general and administrative expenses | 12.6 | (3.4) | — | 9.2 | |||||||||||||||||||
Separation costs | — | — | — | — | |||||||||||||||||||
Research and development | 2.6 | (0.8) | — | 1.7 | |||||||||||||||||||
Interest and other financial charges | 2.1 | (0.1) | — | 2.0 | |||||||||||||||||||
Debt extinguishment costs | 0.3 | — | — | 0.3 | |||||||||||||||||||
Insurance losses and annuity benefits | 2.5 | — | — | 2.5 | |||||||||||||||||||
Goodwill impairments | 0.9 | — | — | 0.9 | |||||||||||||||||||
Non-operating benefit costs (income) | 2.4 | — | (0.8) | (r) | 1.6 | ||||||||||||||||||
Total costs and expenses | 81.3 | (15.1) | (0.6) | 65.6 | |||||||||||||||||||
Other income | 11.4 | — | (12.3) | (t)(u) | (0.9) | ||||||||||||||||||
Earnings (loss) from continuing operations before income taxes | 6.0 | (3.0) | (11.5) | (8.5) | |||||||||||||||||||
Benefit (provision) for income taxes | 0.5 | 0.6 | 1.0 | (v) | 2.2 | ||||||||||||||||||
Earnings (loss) from continuing operations | 6.5 | (2.3) | (10.4) | (6.3) | |||||||||||||||||||
Less net earnings (loss) attributable to noncontrolling interests | (0.2) | (0.1) | — | (0.2) | |||||||||||||||||||
Preferred stock dividends | (0.5) | — | — | (0.5) | |||||||||||||||||||
Net earnings (loss) from continuing operations attributable to GE common shareowners | $ | 6.1 | $ | (2.3) | $ | (10.4) | $ | (6.6) | |||||||||||||||
Per-share amounts | |||||||||||||||||||||||
Earnings (loss) from continuing operations | |||||||||||||||||||||||
Diluted earnings (loss) per share | $ | 5.46 | $ | (6.16) | |||||||||||||||||||
Basic earnings (loss) per share | $ | 5.46 | $ | (6.16) | |||||||||||||||||||
Average equivalent shares (in millions) | |||||||||||||||||||||||
Diluted | 1,095 | 1,094 | |||||||||||||||||||||
Basic | 1,094 | 1,094 |